[1]. Zhang, S., et al., Silencing of cytoskeleton-associated protein 2 represses cell proliferation and induces cell cycle arrest and cell apoptosis in osteosarcoma cells. Biomed Pharmacother, 2018. 106: p. 1396-1403.
[2]. Tang, N., et al., Osteosarcoma development and stem cell differentiation. Clin Orthop Relat Res, 2008. 466(9): p. 2114-30.
[3]. Zocchi, L., et al., The cyclin-dependent kinase inhibitor flavopiridol (alvocidib) inhibits metastasis of human osteosarcoma cells. Oncotarget, 2018. 9(34): p. 23505-23518.
[4]. Anastasiadou, E., L.S. Jacob and F.J. Slack, Non-coding RNA networks in cancer. Nat Rev Cancer, 2018. 18(1): p. 5-18.
[5]. Liyanage, K. and G.U. Ganegoda, Therapeutic Approaches and Role of ncRNAs in Cardiovascular Disorders and Insulin Resistance. Biomed Res Int, 2017. 2017: p. 4078346.
[6]. Kleaveland, B., et al., A Network of Noncoding Regulatory RNAs Acts in the Mammalian Brain. Cell, 2018. 174(2): p. 350-362.e17.
[7]. Kawasaki, Y., et al., MYU, a Target lncRNA for Wnt/c-Myc Signaling, Mediates Induction of CDK6 to Promote Cell Cycle Progression. Cell Rep, 2016. 16(10): p. 2554-2564.
[8]. Wang, K., et al., CARL lncRNA inhibits anoxia-induced mitochondrial fission and apoptosis in cardiomyocytes by impairing miR-539-dependent PHB2 downregulation. Nat Commun, 2014. 5: p. 3596.
[9]. Grote, P., et al., The tissue-specific lncRNA Fendrr is an essential regulator of heart and body wall development in the mouse. Dev Cell, 2013. 24(2): p. 206-14.
[10]. Sun, T.T., et al., LncRNA GClnc1 Promotes Gastric Carcinogenesis and May Act as a Modular Scaffold of WDR5 and KAT2A Complexes to Specify the Histone Modification Pattern. Cancer Discov, 2016. 6(7): p. 784-801.
[11]. Zhang, C.L., K.P. Zhu and X.L. Ma, Antisense lncRNA FOXC2-AS1 promotes doxorubicin resistance in osteosarcoma by increasing the expression of FOXC2. Cancer Lett, 2017. 396: p. 66-75.
[12]. Wang, Z., et al., LncRNA SOX2-OT is a novel prognostic biomarker for osteosarcoma patients and regulates osteosarcoma cells proliferation and motility through modulating SOX2. IUBMB Life, 2017. 69(11): p. 867-876.
[13]. Zuo W, Zhang W, Xu F, Zhou J, Bai W. Long non-coding RNA LINC00485 acts as a microRNA-195 sponge to regulate the chemotherapy sensitivity of lung adenocarcinoma cells to cisplatin by regulating CHEK1. Cancer Cell Int. 2019;19:240.
[14]. Mulholland, E.J., et al., Exploring the Potential of MicroRNA Let-7c as a Therapeutic for Prostate Cancer. Mol Ther Nucleic Acids, 2019. 18: p. 927-937.
[15]. Logotheti, S., S. Marquardt and B.M. Putzer, p73-Governed miRNA Networks: Translating Bioinformatics Approaches to Therapeutic Solutions for Cancer Metastasis. Methods Mol Biol, 2019. 1912: p. 33-52.
[16]. Tutar, Y., miRNA and cancer; computational and experimental approaches. Curr Pharm Biotechnol, 2014. 15(5): p. 429.
[17]. Mishra, S., T. Yadav and V. Rani, Exploring miRNA based approaches in cancer diagnostics and therapeutics. Crit Rev Oncol Hematol, 2016. 98: p. 12-23.
[18]. Tian, L., et al., MiR-361-5p suppresses chemoresistance of gastric cancer cells by targeting FOXM1 via the PI3K/Akt/mTOR pathway. Oncotarget, 2018. 9(4): p. 4886-4896.
[19]. Ma, F., et al., MiR-361-5p inhibits glycolytic metabolism, proliferation and invasion of breast cancer by targeting FGFR1 and MMP-1. J Exp Clin Cancer Res, 2017. 36(1): p. 158.
[20]. Hou, X.W., et al., miR-361-5p suppresses lung cancer cell lines progression by targeting FOXM1. Neoplasma, 2017. 64(4): p. 526-534.
[21] Tischfield MA, Robson CD, Gilette NM, et al. Cerebral Vein Malformations Result from Loss of Twist1 Expression and BMP Signaling from Skull Progenitor Cells and Dura. Dev Cell. 2017;42(5):445–461.e5.
[22] Bildsoe H, Loebel DA, Jones VJ, et al. The mesenchymal architecture of the cranial mesoderm of mouse embryos is disrupted by the loss of Twist1 function. Dev Biol. 2013;374(2):295–307.
[23] Hirsch N, Eshel R, Bar Yaacov R, et al. Unraveling the transcriptional regulation of TWIST1 in limb development. PLoS Genet. 2018;14(10):e1007738. Published 2018 Oct 29.
[24] Pan D, Fujimoto M, Lopes A, Wang YX. Twist-1 is a PPARdelta-inducible, negative-feedback regulator of PGC-1alpha in brown fat metabolism. Cell. 2009;137(1):73–86.
[25]. Zhao, Z., et al., Multiple biological functions of Twist1 in various cancers. Oncotarget, 2017. 8(12): p. 20380-20393.
[26]. Yang, X., et al., Activation of TGF-beta1 Pathway by SCUBE3 Regulates TWIST1 Expression and Promotes Breast Cancer Progression. Cancer Biother Radiopharm, 2019.
[27]. Wang, X.X., et al., TWIST1 transcriptionally regulates glycolytic genes to promote the Warburg metabolism in pancreatic cancer. Exp Cell Res, 2019: p. 111713.
[28]. Meng, J., et al., Twist1 Regulates Vimentin through Cul2 Circular RNA to Promote EMT in Hepatocellular Carcinoma. Cancer Res, 2018. 78(15): p. 4150-4162.
[29]. Kager, L., G. Tamamyan and S. Bielack, Novel insights and therapeutic interventions for pediatric osteosarcoma. Future Oncol, 2017. 13(4): p. 357-368.
[30]. Adekunle, I.A., et al., Non-coding RNA and Lung Cancer Progression. J Chin Med Assoc, 2019.
[31]. Wu, X., et al., LncRNA BANCR Promotes Pancreatic Cancer Tumorigenesis via Modulating MiR-195-5p/Wnt/beta-Catenin Signaling Pathway. Technol Cancer Res Treat, 2019. 18: p. 1533033819887962.
[32]. Wei, X., et al., LncRNA MBNL1-AS1 represses cell proliferation and enhances cell apoptosis via targeting miR-135a-5p/PHLPP2/FOXO1 axis in bladder cancer. Cancer Med, 2019.
[33]. Yang, J., S. Zhao and F. Tian, SP1-mediated lncRNA PVT1 modulates the proliferation and apoptosis of lens epithelial cells in diabetic cataract via miR-214-3p/MMP2 axis. J Cell Mol Med, 2019.
[34]. Huang, L., et al., Silencing of long non-coding RNA NCK1-AS1 inhibits cell proliferation and migration via inhibition of microRNA-134 in cervical cancer. Exp Ther Med, 2019. 18(3): p. 2314-2322.
[35]. Yu, W., et al., lncRNA PTAR promotes NSCLC cell proliferation, migration and invasion by sponging microRNA101. Mol Med Rep, 2019. 20(5): p. 4168-4174.
[36]. Wang, L., et al., Circ_0001658 promotes the proliferation and metastasis of osteosarcoma cells via regulating miR-382-5p/YB-1 axis. Cell Biochem Funct, 2019.
[37]. Gang, W., et al., Inhibition of miR-9 decreases osteosarcoma cell proliferation. Bosn J Basic Med Sci, 2019.
[38]. Ma, F., et al., MiR-361-5p inhibits glycolytic metabolism, proliferation and invasion of breast cancer by targeting FGFR1 and MMP-1. J Exp Clin Cancer Res, 2017. 36(1): p. 158.
[39]. Liu, J., et al., miR-361-5p inhibits glioma migration and invasion by targeting SND1. Onco Targets Ther, 2018. 11: p. 5239-5252.
[40]. Liu Y, Zhou J, Wang S, Song Y, Zhou J, Ren F. Long non-coding RNA SNHG12 promotes proliferation and invasion of colorectal cancer cells by acting as a molecular sponge of microRNA-16. Exp Ther Med. 2019;18(2):1212–1220.
[41] Liu W, Liu PC, Ma K, Wang YY, Chi QB, Yan M. LncRNA DLEU2 promotes tumour growth by sponging miR-337-3p in human osteosarcoma [published online ahead of print, 2020 Mar 20]. Cell Biochem Funct. 2020;10.1002/cbf.3509.
[42] Zhang L, Zhao G, Ji S, Yuan Q, Zhou H. Downregulated Long Non-Coding RNA MSC-AS1 Inhibits Osteosarcoma Progression and Increases Sensitivity to Cisplatin by Binding to MicroRNA-142. Med Sci Monit. 2020;26:e921594.
[43] Yang B, Zhang W, Zhang M, Wang X, Peng S, Zhang R. KRT6A Promotes EMT and Cancer Stem Cell Transformation in Lung Adenocarcinoma. Technol Cancer Res Treat. 2020;19:1533033820921248.
[44] Saitoh M. Involvement of partial EMT in cancer progression. J Biochem. 2018;164(4):257–264.
[45] Ma Z, Yang J, Yang Y, et al. Rosmarinic acid exerts an anticancer effect on osteosarcoma cells by inhibiting DJ-1 via regulation of the PTEN-PI3K-Akt signaling pathway. Phytomedicine. 2020;68:153186.
[46] Wang Y, Wang H, Zhou R, et al. Baicalin inhibits human osteosarcoma cells invasion, metastasis, and anoikis resistance by suppressing the transforming growth factor-β1-induced epithelial-to-mesenchymal transition. Anticancer Drugs. 2017;28(6):581–587.
[47]. Martin, A. and A. Cano, Tumorigenesis: Twist1 links EMT to self-renewal. Nat Cell Biol, 2010. 12(10): p. 924-5.
[48] Shi D, Wu F, Mu S, et al. LncRNA AFAP1-AS1 promotes tumorigenesis and epithelial-mesenchymal transition of osteosarcoma through RhoC/ROCK1/p38MAPK/Twist1 signaling pathway. J Exp Clin Cancer Res. 2019;38(1):375. Published 2019 Aug 23.
[49] Jia J, Yin P, Han G, Xu M, Wang W, Bi W. MicroRNA-300 decreases cell viability, inhibits migration and promotes apoptosis of osteosarcoma cells via downregulation of Twist1. Mol Med Rep. 2017;16(3):3613–3618.